Is Annular Reduction the Answer to Tricuspid Regurgitation?
- PMID: 34317134
- PMCID: PMC8299970
- DOI: 10.1016/j.jaccas.2020.10.010
Is Annular Reduction the Answer to Tricuspid Regurgitation?
Keywords: 3-dimensional imaging; right ventricle; tricuspid valve; valve repair.
Conflict of interest statement
Dr. Dreyfus has held teaching courses for Edwards Lifesciences. Dr. Caussin has been a proctor for Edwards Lifesciences, Abbott Laboratories, Medtronic, and Boston Scientific. Dr. Dulguerov has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jaccas.2020.08.032
References
-
- Enriquez-Sarano M., Messika-Zeitoun D., Topilsky Y. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis. 2019;62:447–451. - PubMed
-
- Topilsky Y., Maltais S., Medina Inojosa J. Burden of tricuspid regurgitation in patients diagnosed in the community setting. J Am Coll Cardiol Img. 2019;12:433–442. - PubMed
-
- Topilsky Y., Nkomo V.T., Vatury O. Clinical outcome of isolated tricuspid regurgitation. J Am Coll Cardiol Img. 2014;7:1185–1194.
-
- Benfari G., Antoine C., Miller W.L. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140:196–206. - PubMed
-
- Essayagh B., Antoine C., Benfari G. Functional tricuspid regurgitation of degenerative mitral disease: a crucial determinant of survival. Eur Heart J. 2020;41:1918–1929. - PubMed
Publication types
LinkOut - more resources
Full Text Sources